Chelation therapy: a reappraisal.

N Z Med J

Published: January 1983

Download full-text PDF

Source

Publication Analysis

Top Keywords

chelation therapy
4
therapy reappraisal
4
chelation
1
reappraisal
1

Similar Publications

Toxoplasmosis induced by Toxoplasma gondii is a well-known health threat, that prompts fatal encephalitis increased with immunocompromised patients, in addition, it can cause chorioretinitis, microcephaly, stillbirth in the fetus and even led to death. Standard therapy uses sulfadiazine and pyrimethamine drugs revealed beneficial results during the acute stage, however, it has severe side effects. UPLC-ESI-MS/MS used to explore C.

View Article and Find Full Text PDF

Iron overload has been associated with cerebrovascular disease and cognitive impairment in β-thalassaemia patients, typically appearing earlier than in the general population. However, the mechanisms of iron overload on cerebrovascular pathology remain unclear. This study investigated the effects of heavy iron overload on the blood-brain barrier and neurohistology, particularly in the CA3 region of hippocampus and its contribution to cognitive impairment in β-thalassaemia mice.

View Article and Find Full Text PDF

Multifunctional selenium-doped carbon dots for modulating Alzheimer's disease related toxic ions, inhibiting amyloid aggregation and scavenging reactive oxygen species.

Int J Biol Macromol

December 2024

Department of Chemistry, School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, 127 Youyi Road, Xi'an 710072, China. Electronic address:

Article Synopsis
  • β-Amyloid deposition, oxidative stress, and metal ion imbalance are key features of Alzheimer's disease, creating a need for effective multi-target therapies.
  • Researchers developed multifunctional selenium-doped carbonized polymer dots (SeCDs) to inhibit Aβ aggregation, reduce reactive oxygen species (ROS), and chelate copper ions.
  • SeCDs successfully clear harmful radicals and bind Cu ions, lowering cytotoxicity related to Aβ-Cu complexes, and show promise as a treatment option by reducing intracellular ROS levels.
View Article and Find Full Text PDF
Article Synopsis
  • Thalassemia, particularly beta-thalassemia major, is a hereditary anemia marked by insufficient beta-globin chain production, leading to iron overload from frequent blood transfusions, with significant health complications like endocrinopathies.
  • The study focused on children aged 6 months to 14 years, examining growth and endocrine function in relation to serum ferritin levels, which indicate iron overload.
  • Results revealed a high prevalence of endocrinopathy, with short stature being the most commonly observed issue, particularly among boys and younger children.
View Article and Find Full Text PDF

Targeting iron metabolism has emerged as a novel therapeutic strategy for the treatment of cancer. As such, iron chelator drugs are repurposed or specifically designed as anticancer agents. Two important chelators, deferasirox (Def) and triapine (Trp), attack the intracellular supply of iron (Fe) and inhibit Fe-dependent pathways responsible for cellular proliferation and metastasis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!